However, individual patient circumstances should always be considered, and any concerns about thrombotic risk should be discussed with the prescribing clinician
Polymorphism in Glutamate-Cysteine Ligase Modifier Subunit Gene Is Associated with Impairment of Nitric Oxide-Mediated Coronary Vasomotor Function
doi:10.1101/cshperspect.a040576
Prescribed to treat obesity, Wegovy is part of a class of drugs called GLP-1 receptor agonists, which also includes Ozempic, Trulicity, and Mounjaro
For anyone experiencing any of the symptoms above, its important to seek help from a qualified medical provider and begin appropriate treatment
PMCID: PMC6973035 Wozniak-Mielczarek L, Osowicka M, Radtke-Lysek A, Drezek-Nojowicz M, Gilis-Malinowska N, Sabiniewicz A, Mielczarek M, Sabiniewicz R